AbbVie (United States)

161.2k citations
7.0k papers ·

Impact in

  • Hepatology top 2%
    • Hepatitis C virus research
  • Genetics top 2%
    • Chronic Lymphocytic Leukemia Research
    • Inflammatory Bowel Disease

Papers in

    • Chronic Lymphocytic Leukemia Research 551
    • Inflammatory Bowel Disease 316
    • Hepatitis C virus research 319

AbbVie (United States)

6.1k papers receiving 142.9k citations

Peers

AbbVie (United States)
Comparison fields: 5 of 231
  • Hepatology 9.3k
  • Genetics 11.6k
  • Hematology 12.4k
  • Pharmaceutical Science 4.9k
  • Immunology 15.9k
Replace Abbott Fund with:
Abbott Fund United States
Abbott (United States) United States
Robert H. Lurie Comprehensive Cancer Center of Northwestern University United States
Takeda (United States) United States
University of Wisconsin Carbone Cancer Center United States
Cleveland Clinic Lerner College of Medicine United States
Baxter (United States) United States
Radiation Oncology Associates United States
Michigan Center for Translational Pathology United States
Sarah Cannon United States
AbbVie (United States) relative to Abbott Fund United States Abbott Fund's profile →
Citations per field
00.5×5.7×
Abbott Fund · 1×
Citations per year

Countries citing scholars working at AbbVie (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at AbbVie (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AbbVie (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AbbVie (United States) more than expected).

Fields of papers published by authors at AbbVie (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with AbbVie (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with AbbVie (United States) at the time of their publication.

About AbbVie (United States)

In recent decades, authors affiliated with AbbVie (United States) have published 7.0k papers, which have received a total of 161.2k indexed citations . Scholars at this organization have produced 665 papers in Genetics, 351 papers in Hepatology, 486 papers in Hematology, 597 papers in Rheumatology and 716 papers in Immunology on the topics of Chronic Lymphocytic Leukemia Research (551 papers), Rheumatoid Arthritis Research and Therapies (340 papers), Hepatitis C virus research (319 papers), Inflammatory Bowel Disease (316 papers), Lymphoma Diagnosis and Treatment (304 papers), Monoclonal and Polyclonal Antibodies Research (290 papers), Psoriasis: Treatment and Pathogenesis (213 papers) and Biosimilars and Bioanalytical Methods (210 papers). Their work is cited by papers focused on Hepatology (9.3k citations), Genetics (11.6k citations), Hematology (12.4k citations), Pharmaceutical Science (4.9k citations) and Immunology (15.9k citations). Authors at AbbVie (United States) collaborate with scholars in United States, Germany and United Kingdom and have published in prestigious journals including Blood, Annals of the Rheumatic Diseases, Journal of Clinical Oncology, Journal of Crohn s and Colitis and Journal of Pharmaceutical Sciences. Some of AbbVie (United States)'s most productive authors include Geoff G. Z. Zhang, Rolando Burgos, Ahmed M. Soliman, Dushan Boroyevich, Lynne S. Taylor, Aileen L. Pangan, Carl J. Lavie, Joel D. Leverson, Ahmed Hamed Salem and Reynaldo Nuqui.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact